Symptoms and Well-Being in Relation to Glycemic Control in Type II Diabetes

Does, F. E. E. Van Der; Neeling, J.N.D. de; Snoek, Frank J.; Kostense, Pieter J.; Grootenhuis, P.A.; Bouter, Lex M.; Heine, Robert J.

doi:10.2337/diacare.19.3.204

Cited by 233 publications

(157 citation statements)

References 11 publications

Supporting

Mentioning

134

Contrasting

Unclassified

Order By: Relevance

“…QoL, assessed by other tools, was reported to correlate with metabolic control in Type II diabetes in a cross-sectional survey [28] and with onset of complications, independently of intensive pharmacological treatment, in a longitudinal study [29]. Our results suggest that it could progressively worsen in Type II diabetes, along with increasing HbA 1c and/or the emergence of complications.…”

Section: Discussionmentioning

confidence: 57%

Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial

et al. 2002

View full text Add to dashboard Cite

Aims/hypothesis. Metabolic control worsens progressively in Type II (non-insulin-dependent) diabetes mellitus despite intensified pharmacological treatment and lifestyle intervention, when these are implemented on a one-to-one basis. We compared traditional individual diabetes care with a model in which routine follow-up is managed by interactive group visits while individual consultations are reserved for emerging medical problems and yearly checks for complications. Methods. A randomized controlled clinical trial of 56 patients with non-insulin-treated Type II diabetes managed by systemic group education and 56 control patients managed by individual consultations and education. Results. Observation times were 51.2±2.1 months for group care and 51.2±1.8 for control subjects. Glycated haemoglobin increased in the control group but not in the group of patients (p<0.001), in whom BMI decreased (p<0.001) and HDL-cholesterol increased (p<0.001). Quality of life, knowledge of diabetes and health behaviours improved with group care (p<0.001, all) and worsened among the control patients (p=0.004 to p<0.001). Dosage of hypoglycaemic agents decreased (p<0.001) and retinopathy progressed less (p<0.009) among the group care patients than the control subjects. Diastolic blood pressure (p<0.001) and relative cardiovascular risk (p<0.05) decreased from baseline in group patients and control patients alike. Over the study period, group care required 196 min and 756.54 US $ per patient, compared with 150 min and 665.77 US $ for the control patients, resulting in an additional 2.12 US $ spent per point gained in the quality of life score. Conclusion/interpretation. Group care by systemic education is feasible in an ordinary diabetes clinic and cost-effective in preventing the deterioration of metabolic control and quality of life in Type II diabetes without increasing pharmacological treatment. [Diabetologia (2002)

show abstract

Section: Discussionmentioning

confidence: 57%

Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial

et al. 2002

View full text Add to dashboard Cite

show abstract

“…Good glycemic control is associated with lower risk for short-term complications (e.g., hyperglycemia), long-term co-morbid conditions (e.g., cardiovascular disease), and mortality (Andersson & Svärdsudd, 1995;Klein, Klein, & Moss, 1996). Further, patients with good glycemic control report better life quality and higher subjective well-being (Rubin & Peyrot, 1999;Van der Does et al, 1996).…”

Section: Beliefs About Willpower Are Related To Therapy Adherence Andmentioning

confidence: 99%

Beliefs About Willpower Are Related to Therapy Adherence and Psychological Adjustment in Patients With Type 2 Diabetes

Bernecker

Job

2015

Basic and Applied Social Psychology

View full text Add to dashboard Cite

Research suggests that self-control, the ability to forego immediate needs for the sake of future rewards, promotes health behavior. The present study examined the role of beliefs about willpower as predictor of self-control in the context of diabetes. Seventy-nine type 2 diabetes patients reported their beliefs about willpower, therapy adherence (i.e., self-care activities, diet, exercise), and psychological adjustment (i.e., emotional distress, well-being, life quality). Endorsing the belief that willpower is a lim-ited versus nonlimited resource was associated with lower therapy adherence and lower psychological adjustment. How people think about their willpower might be crucial for therapy success in diabetes patients. The authors agree to comply with the data-sharing standard of the APA (Ethical Standard 8.14) and provide public access to their data. This research was funded by the Swiss National Science Foundation (grant number PZ00P1_131858). WILLPOWER THEORIES AND DIABETES 2 AbstractResearch suggests that self-control, the ability to forego immediate needs for the sake of

show abstract

“…12 Patients feel better when their blood glucose levels are under control. 13 While quality of life data from the UKPDS detected no adverse effect of hypoglycaemia on well-being, 14 the selection and use of an appropriate low dose insulin may reduce the effects of rapid normalization of glycaemia, and reduce the risk of hypoglycaemia during dose titration. 15 Studies of new insulin analogues, such as the rapid-acting insulin aspart, in Type 1 diabetes suggest that their use can improve postprandial control and glucose excursions in general, and at the same time reduce the likelihood of major hypoglycaemic episodes in comparison to traditional human insulin-based regimens.…”

Section: Prevention Of Hypoglycaemiamentioning

confidence: 99%

When oral agents fail: practical barriers to starting insulin

2002

View full text Add to dashboard Cite

Insulin therapy has proven benefits in Type 2 diabetes patients when combination therapy has failed. However, there is some reluctance by both patients and healthcare professionals to initiate insulin therapy. This reluctance has been termed 'psychological insulin resistance'. Barriers to the initiation of insulin therapy include patients' fear of disease progression and needle anxiety; mutual concerns about hypoglycaemia and weight gain; and health professionals' use of insulin as a threat to encourage compliance with earlier therapies. It is essential that these obstacles are identified and investigated as a means of overcoming these impediments to recommended levels of glycaemic control, an initiative being pursued by the DAWN study. Where concerns are tangible, such as fear of hypoglycaemia, therapeutic solutions can be pursued. Overcoming psychological barriers relies more on innovative management techniques. Improving insulin delivery to meet these needs, coupled with enhanced healthcare services, can address psychological insulin resistance and contribute to the maintenance of good metabolic control.

show abstract

Symptoms and Well-Being in Relation to Glycemic Control in Type II Diabetes

Abstract: These data suggest that better glycemic control in type II diabetes is associated with fewer physical symptoms, better mood, and better well-being, in a nonhypoglycemic HbA1c range.

Cited by 233 publications

References 11 publications

Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial

Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial

Beliefs About Willpower Are Related to Therapy Adherence and Psychological Adjustment in Patients With Type 2 Diabetes

When oral agents fail: practical barriers to starting insulin

Contact Info

Product

Resources

About